Cost-Effectiveness Analysis of the Adjunctive Therapy of Ivabradine for the Treatment of Heart Failure with Reduced Ejection Fraction.
Rungroj KrittayaphongJirawit YadeeUnchalee PermsuwanPublished in: ClinicoEconomics and outcomes research : CEOR (2019)
This study revealed the addition of ivabradine to standard treatment to be a cost-effective treatment strategy in HFrEF patients with a heart rate ≥77 bpm.